State of Alaska Department of Revenue’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,017
Closed -$278K 1618
2023
Q2
$278K Sell
13,017
-427
-3% -$9.12K ﹤0.01% 1556
2023
Q1
$543K Sell
13,444
-124
-0.9% -$5.01K 0.01% 1324
2022
Q4
$631K Buy
13,568
+80
+0.6% +$3.72K 0.01% 1237
2022
Q3
$699K Sell
13,488
-457
-3% -$23.7K 0.01% 1118
2022
Q2
$659K Buy
13,945
+1,250
+10% +$59.1K 0.01% 1209
2022
Q1
$903K Sell
12,695
-45
-0.4% -$3.2K 0.01% 1086
2021
Q4
$952K Sell
12,740
-385
-3% -$28.8K 0.01% 1116
2021
Q3
$745K Buy
13,125
+690
+6% +$39.2K 0.01% 1263
2021
Q2
$547K Buy
12,435
+282
+2% +$12.4K 0.01% 1407
2021
Q1
$599K Sell
12,153
-1,750
-13% -$86.3K 0.01% 1337
2020
Q4
$585K Sell
13,903
-2,800
-17% -$118K 0.01% 1273
2020
Q3
$764K Buy
16,703
+1,420
+9% +$65K 0.01% 1017
2020
Q2
$767K Buy
15,283
+460
+3% +$23.1K 0.01% 1021
2020
Q1
$762K Buy
14,823
+2,755
+23% +$142K 0.01% 891
2019
Q4
$745K Sell
12,068
-181
-1% -$11.2K 0.01% 1079
2019
Q3
$735K Buy
12,249
+6,827
+126% +$410K 0.01% 1060
2019
Q2
$457K Buy
5,422
+115
+2% +$9.69K 0.01% 1106
2019
Q1
$506K Buy
5,307
+25
+0.5% +$2.38K 0.01% 1052
2018
Q4
$374K Buy
5,282
+200
+4% +$14.2K 0.01% 1128
2018
Q3
$434K Buy
5,082
+352
+7% +$30.1K 0.01% 1192
2018
Q2
$548K Buy
4,730
+90
+2% +$10.4K 0.01% 1022
2018
Q1
$375K Buy
4,640
+1,800
+63% +$145K 0.01% 1124
2017
Q4
$166K Buy
2,840
+90
+3% +$5.26K ﹤0.01% 1362
2017
Q3
$128K Buy
2,750
+20
+0.7% +$931 0.01% 1124
2017
Q2
$98K Buy
2,730
+1,190
+77% +$42.7K 0.01% 1111
2017
Q1
$47K Buy
1,540
+40
+3% +$1.22K ﹤0.01% 1128
2016
Q4
$50K Buy
+1,500
New +$50K ﹤0.01% 836